We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

60 hedge funds and large institutions have $20.4M invested in Marker Therapeutics in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

3% more funds holding

Funds holding: 58 → 60 (+2)

0.1% less ownership

Funds ownership: 3.03% → 2.93% (-0.1%)

4% less capital invested

Capital invested by funds: $21.2M → $20.4M (-$800K)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
16
Closed
6
Calls
$438K
Puts
–
Net Calls
+$438K
Net Calls Change
+$77K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$160K
2
Renaissance Technologies
Renaissance Technologies
New York
+$142K
3
GCP
GSA Capital Partners
United Kingdom
+$94.3K
4
JP Morgan Chase
JP Morgan Chase
New York
+$75.3K
5
VF
Virtu Financial
New York
+$52.8K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$298K
2
PPA
Parametric Portfolio Associates
Washington
-$179K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$101K
4
Wells Fargo
Wells Fargo
California
-$54K
5
WS
Wedbush Securities
California
-$40.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$4K -$683 -44 -13%
TWM
52
Tradition Wealth Management
Minnesota
$4K +$3.91K +252 New
AIP
53
Ameritas Investment Partners
Nebraska
$3K – – –
TWA
54
TCI Wealth Advisors
Arizona
$1K -$1.09K -70 -58%
HNB
55
Huntington National Bank
Ohio
$1K – – –
JCM
56
Jacobi Capital Management
Pennsylvania
$1K – – –
PAM
57
Panagora Asset Management
Massachusetts
$1K – – –
SFS
58
Sowell Financial Services
Arkansas
$1K – – –
AIG
59
American International Group
New York
$26 +$93 +6 +0.3%
Russell Investments Group
60
Russell Investments Group
United Kingdom
– -$298K -19,874 Closed
Jane Street
61
Jane Street
New York
– -$37K -2,441 Closed
Mercer Global Advisors
62
Mercer Global Advisors
Colorado
– -$34K -2,293 Closed
Envestnet Asset Management
63
Envestnet Asset Management
Illinois
– -$32K -2,141 Closed
LPL Financial
64
LPL Financial
California
– -$23K -1,565 Closed
SPIA
65
Steward Partners Investment Advisory
New York
– -$4K -250 Closed
Simplex Trading
66
Simplex Trading
Illinois
– +$171 +11 New
1 2
3

MRKR Hedge Fund Activity: Q4 2020 in Review

60 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q4 2020, worth a combined $20.4M — down 3.8% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MRKR positions and 6 closed out — a net gain of 2 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $160K. The largest seller was Russell Investments Group, exiting entirely with an estimated $298K sold.

  • 60 institutional investors held Marker Therapeutics (MRKR) as of Q4 2020, up from 58 in Q3 2020.
  • Funds reported $20.4M of Marker Therapeutics stock for Q4 2020, down 3.8% quarter-over-quarter.
  • 8 funds opened new Marker Therapeutics positions in Q4 2020 and 6 closed out, a net change of +2 holders.
  • The largest Marker Therapeutics buyer in Q4 2020 was BlackRock, an estimated $160K added.
  • The largest Marker Therapeutics seller in Q4 2020 was Russell Investments Group, an estimated $298K sold.

Based on aggregated 13F filings for Q4 2020.